283 related articles for article (PubMed ID: 28982650)
1. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
2. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
[TBL] [Abstract][Full Text] [Related]
4. Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.
Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Kuriki H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Endo M; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Nishikawa N; Hamajima N; Shirato N; Yotsumoto J; Nishiyama M; Koide K; Hirose T; Sago H
Prenat Diagn; 2019 Jan; 39(2):100-106. PubMed ID: 30586157
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations.
Lenaerts L; Che H; Brison N; Neofytou M; Jatsenko T; Lefrère H; Maggen C; Villela D; Verheecke M; Dehaspe L; Croitor A; Hatse S; Wildiers H; Neven P; Vandecaveye V; Floris G; Vermeesch JR; Amant F
Clin Chem; 2020 Nov; 66(11):1414-1423. PubMed ID: 33141904
[TBL] [Abstract][Full Text] [Related]
6. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
[TBL] [Abstract][Full Text] [Related]
7. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract][Full Text] [Related]
8. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
9. Copy number variation profile in noninvasive prenatal testing (NIPT) can identify co-existing maternal malignancies: Case reports and a literature review.
Ji X; Chen F; Zhou Y; Li J; Yuan Y; Mo Y; Liu Q; Tseng JY; Shih-Chieh Lin D; Shen SH; Liu Y; Ye W; Cheung YN; Yuen KY; Lin S; Fu M; Zhang H; Liu N; Wang J; Yang H; Wang Y; Li S; Fan S; Jin X; Mao M; Sung PL
Taiwan J Obstet Gynecol; 2018 Dec; 57(6):871-877. PubMed ID: 30545544
[TBL] [Abstract][Full Text] [Related]
10. Early detection of active Human CytomegaloVirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing.
Faas BHW; Astuti G; Melchers WJG; Reuss A; Gilissen C; Macville MVE; Ghesquiere SAI; Houben LMH; Srebniak MI; Geeven G; Rahamat-Langendoen JC; Sistermans EA; Linthorst J
EBioMedicine; 2024 Feb; 100():104983. PubMed ID: 38365322
[TBL] [Abstract][Full Text] [Related]
11. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
[TBL] [Abstract][Full Text] [Related]
12. Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA.
Kwon HJ; Yun S; Joo J; Park D; Do WJ; Lee S; Lee MS
Prenat Diagn; 2023 Dec; 43(13):1581-1592. PubMed ID: 37975672
[TBL] [Abstract][Full Text] [Related]
13. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies.
Brison N; Van Den Bogaert K; Dehaspe L; van den Oever JM; Janssens K; Blaumeiser B; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
Genet Med; 2017 Mar; 19(3):306-313. PubMed ID: 27584908
[TBL] [Abstract][Full Text] [Related]
14. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.
Gerundino F; Giachini C; Contini E; Benelli M; Marseglia G; Giuliani C; Marin F; Nannetti G; Lisi E; Sbernini F; Periti E; Cordisco A; Colosi E; D'ambrosio V; Mazzi M; Rossi M; Staderini L; Minuti B; Pelo E; Cicatiello R; Maruotti GM; Sglavo G; Conti A; Frusconi S; Pescucci C; Torricelli F
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):710-716. PubMed ID: 27226231
[TBL] [Abstract][Full Text] [Related]
15. Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment.
Nakamura N; Sasaki A; Mikami M; Nishiyama M; Akaishi R; Wada S; Ozawa N; Sago H
Prenat Diagn; 2020 Jun; 40(7):838-845. PubMed ID: 32274797
[TBL] [Abstract][Full Text] [Related]
16. [Analysis to the failure rate and causes of noninvasive prenatal testing based on high-throughput sequencing].
Wang W; Duan H; Ding W; Zhang Y; Zhu R; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1171-1175. PubMed ID: 34839500
[TBL] [Abstract][Full Text] [Related]
17. Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results.
Bianchi DW
Genet Med; 2018 Sep; 20(9):910-917. PubMed ID: 29215645
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.
Yin AH; Peng CF; Zhao X; Caughey BA; Yang JX; Liu J; Huang WW; Liu C; Luo DH; Liu HL; Chen YY; Wu J; Hou R; Zhang M; Ai M; Zheng L; Xue RQ; Mai MQ; Guo FF; Qi YM; Wang DM; Krawczyk M; Zhang D; Wang YN; Huang QF; Karin M; Zhang K
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14670-5. PubMed ID: 26554006
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.
Vong JSL; Jiang P; Cheng SH; Lee WS; Tsang JCH; Leung TY; Chan KCA; Chiu RWK; Lo YMD
Prenat Diagn; 2019 Jan; 39(2):88-99. PubMed ID: 30575063
[TBL] [Abstract][Full Text] [Related]
20. Using Targeted Sequencing of Paralogous Sequences for Noninvasive Detection of Selected Fetal Aneuploidies.
Ellison CK; Sun Y; Hogg G; Fox J; Tao H; McCarthy E; Sagoe B; Azab MA; Mazloom AR; Tynan J; Burcham T; Kim SK; van den Boom D; Ehrich M; Jensen TJ
Clin Chem; 2016 Dec; 62(12):1621-1629. PubMed ID: 27694391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]